Dicerna Pharmaceuticals OverviewDicerna Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for DRNA.
Quarterly Other Income/Expense
$4.01M
↑ 281.54% YoY
As of Sep 30, 2021
Annual Other Income/Expense (TTM)
-$1.81M
↓ 125.53% YoY
Trailing 12 months ending Sep 30, 2021